IRCT20180125038507N1 IRCT 2018-08-03 Tehran University of Medical Sciences Study of therapeutic effects of Atomoxtein in reducing the symptoms of patients with recurrent vasovagal syncope Study of the therapeutic effects of Atomoxetine in comparison with placebo on reducing the incidence of symptoms in patients with recurrent vasovagal syncope; 2018-07-23 anticipated 50 Complete https://irct.ir/trial/32875 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients are randomized and divided into two groups based on permutation blocks and they fall into one of the medication and placebo groups, Blinding description: This is a double-blind study. Both patients and investigators were blinded to the medication and placebo. 3 Syncope. Intervention 1: Intervention group: Atomoxetine 20 mg daily, taken orally, for 2 weeks and 40 mg daily for another 2 weeks, if tolerated. The pills will be sealed in 2 envelopes for each 2-week period: 14 pills (20 mg) in envelope A and 14 pills (40 mg) in envelope B. Intervention 2: Control group: Placebo pills are administered orally daily for a period of 4 weeks in envelopes A and B as discussed earlier. Placebos will be produced by the pharmacy department of Tehran University of Medical Sciences. Yes - There is a plan to make this available What will be shared: All data will be published When: 2019 To whom: All Conditions: All Where to obtain: Dr Masih Tajdini How to obtain: Appointment Comments: